PHAR is Pharming Group N.V. (Healthcare) — a non-dividend-paying stock. Trading at $11.70. Market cap: $828M. Capital Quality Rank: 100/100 — Market alpha.
Stock snapshot
| Price | $11.70 |
| Market cap | $828M |
| Sector | Healthcare |
| Exchange | NGM |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 100 / 100 · Market alpha |
| ROIC (TTM) | 9.1% |
| Revenue CAGR (3y) | 22.3% |
| Shareholder buyback yield | 15.00% |
| Altman Z-score zone | Grey |
About PHAR
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.
Related non-dividend companies
Other non-dividend stocks investors research alongside PHAR. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is PHAR's current stock price?
PHAR (Pharming Group N.V.) is currently trading at $11.70.
Does PHAR pay a dividend?
PHAR (Pharming Group N.V.) does not currently pay a regular dividend.
What is PHAR's Capital Quality Rank?
PHAR has a Capital Quality Rank of 100/100 — Market alpha. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track PHAR in DiviDrip
Add PHAR to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search PHAR and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-08-30. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.
